https://www.worldpharmaceuticals.net/news/mercks-gardasil-9-vaccine-meets-primary-endpoint-in-phase-3-trial/ 2024-09-12T13:52:22+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/Headquarters_Rahway-Site-Entrance_3_HI.webp https://www.worldpharmaceuticals.net/news/sanofis-dupixent-improves-itch-and-hives-in-phase-3-csu-trial/ 2024-09-12T14:24:04+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/sam-moghadam-khamseh-2rrsfMN4hn8-unsplash.webp https://www.worldpharmaceuticals.net/news/lilly-to-invest-1-8bn-to-expand-manufacturing-footprint-in-ireland/ 2024-09-13T06:42:58+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/MounjaroPen_15_RGB.webp https://www.worldpharmaceuticals.net/news/chinas-nmpa-approves-keymeds-stapokibart-for-atopic-dermatitis/ 2024-09-13T10:02:45+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/hand-663726_1920.webp https://www.worldpharmaceuticals.net/news/us-fda-approves-genentechs-tecentriq-hybreza-for-sc-administration/ 2024-09-13T11:40:33+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/New-Project-55.webp https://www.worldpharmaceuticals.net/news/sanofi-radiomedix-and-orano-med-partner-on-alphamedix/ 2024-09-13T11:59:36+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/New-Project-58-1.webp https://www.worldpharmaceuticals.net/news/lilly-secures-fda-approval-for-ebglyss-to-treat-atopic-dermatitis/ 2024-09-16T09:19:21+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/New-Project-67.webp https://www.worldpharmaceuticals.net/news/dupixent-gains-fda-approval-for-expanded-use-in-adolescents-with-crswnp/ 2024-09-16T10:35:47+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/doctor-1228627_1920-2.webp https://www.worldpharmaceuticals.net/news/jjs-rybrevant-plus-chemotherapy-shows-promise-in-lung-cancer/ 2024-09-16T12:21:15+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/New-Project-71.webp https://www.worldpharmaceuticals.net/news/pfizers-braftovi-and-mektovi-show-long-term-benefit-in-nsclc-phase-2-trial/ 2024-09-16T14:06:47+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/lab-3498584_1920-1.webp https://www.worldpharmaceuticals.net/news/novo-nordisk-korro-bio-partner-for-genetic-medicines/ 2024-09-17T07:58:41+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/New-Project-79.webp https://www.worldpharmaceuticals.net/news/jj-announces-positive-results-for-tar-200/ 2024-09-17T11:59:01+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/New-Project-82.webp https://www.worldpharmaceuticals.net/news/debiopharm-partners-with-whitelab-genomics-to-enhance-drug-targeting-in-oncology/ 2024-09-17T12:00:52+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/laboratory-3827738_1920-2.webp https://www.worldpharmaceuticals.net/news/fda-grants-rmat-status-to-poseidas-p-bcma-allo1-for-relapsed-refractory-multiple-myeloma/ 2024-09-17T12:39:40+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/analysis-7091203_1920.webp https://www.worldpharmaceuticals.net/news/novartis-gets-fda-approval-for-kisqali-to-treat-early-breast-cancer/ 2024-09-18T06:38:39+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/New-Project-86.webp https://www.worldpharmaceuticals.net/news/pharmajet-and-scancell-partner-on-needle-free-dna-vaccine-for-melanoma/ 2024-09-18T09:01:43+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/trnava-university-oXbIT5HnQbQ-unsplash.webp https://www.worldpharmaceuticals.net/news/seran-secures-200m-investment-to-build-new-commercial-facility-in-oregon-us/ 2024-09-18T10:48:08+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/New-Project-89.webp https://www.worldpharmaceuticals.net/news/beigenes-tevimbra-gets-israeli-approval-for-oesophageal-squamous-cell-carcinoma/ 2024-09-18T12:49:37+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/BeiGene_%E9%9B%AA%E6%99%AF%E7%99%BE%E6%B5%8E%E7%A5%9E%E5%B7%9E_-_panoramio-1.webp https://www.worldpharmaceuticals.net/news/us-fda-approves-astrazenecas-fasenra-for-adults-with-egpa/ 2024-09-19T11:49:21+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/original-1.webp https://www.worldpharmaceuticals.net/news/organon-to-acquire-dermavant-for-1-2bn/ 2024-09-19T12:26:09+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/New-Project-104.webp https://www.worldpharmaceuticals.net/news/gsk-reports-positive-results-from-arexvy-shingrix-co-administration-trial/ 2024-09-19T12:51:56+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/Gsk-Rd-Stevenage-Uk-22720103947-O-1.webp https://www.worldpharmaceuticals.net/news/nanovation-partners-with-novo-nordisk/ 2024-09-19T14:46:21+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/New-Project-108.webp https://www.worldpharmaceuticals.net/news/nhs-england-green-lights-quizartinib-for-blood-cancer-treatment/ 2024-09-20T09:58:08+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/NHS_England_HQ.webp https://www.worldpharmaceuticals.net/news/vandas-tradipitant-fails-to-secure-fda-approval-for-gastroparesis/ 2024-09-20T11:27:57+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/vanda-20thSept.webp https://www.worldpharmaceuticals.net/news/emas-chmp-recommends-wegovy-for-obesity-related-heart-condition/ 2024-09-20T12:40:23+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/original-2.webp https://www.worldpharmaceuticals.net/news/bavarian-nordics-imvanex-vaccine-gets-ema-nod-for-adolescents/ 2024-09-20T13:16:26+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/medical-5037940_1920.webp https://www.worldpharmaceuticals.net/news/uks-mhra-approves-fruzaqla-to-treat-colorectal-cancer/ 2024-09-23T09:15:10+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/New-Project-112.webp https://www.worldpharmaceuticals.net/news/ec-approves-vyloy-with-chemotherapy-for-gastric-and-gej-cancer/ 2024-09-23T11:59:58+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/injection-1973104_1920.webp https://www.worldpharmaceuticals.net/news/ec-approves-iqirvo-plus-udca-to-treat-primary-biliary-cholangitis/ 2024-09-23T13:32:33+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/New-Project-115.webp https://www.worldpharmaceuticals.net/news/fda-approves-miplyffa-for-niemann-pick-disease-type-c-treatment/ 2024-09-23T13:47:20+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/connective-tissue-7068088_1920.webp https://www.worldpharmaceuticals.net/news/fda-approves-bimzelx-in-three-new-indications/ 2024-09-24T09:20:16+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/New-Project.webp https://www.worldpharmaceuticals.net/news/leo-pharma-secures-ec-approval-for-anzupgo-cream-to-treat-hand-eczema/ 2024-09-24T11:28:09+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/New-Project-127.webp https://www.worldpharmaceuticals.net/news/ec-approves-ipsens-kayfanda-for-cholestatic-pruritus-in-algs/ 2024-09-24T13:20:03+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/8-1.webp https://www.worldpharmaceuticals.net/news/fda-accepts-aptars-n-sorb-for-emerging-technology-program/ 2024-09-24T14:02:35+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/Blister_render_300dpi_9.15.20_BlueTablets_with_N-SORB_callout.webp https://www.worldpharmaceuticals.net/news/novartis-taps-generatebiomedicines-to-develop-new-drugs/ 2024-09-25T09:28:26+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/New-Project-131.webp https://www.worldpharmaceuticals.net/news/japans-health-regulator-mhlw-approves-five-new-medications/ 2024-09-25T12:18:40+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/New-Project-133.webp https://www.worldpharmaceuticals.net/news/junshis-toripalimab-secures-ec-approval-for-npc-and-escc/ 2024-09-25T13:25:30+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/syringe-5904302_1920.webp https://www.worldpharmaceuticals.net/news/bavarian-nordic-secures-additional-63m-order-in-us-for-jynneos-production/ 2024-09-25T13:39:51+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/vial-5774206_1920.webp https://www.worldpharmaceuticals.net/news/askbio-belief-biomed-partner-to-explore-new-therapies/ 2024-09-26T11:45:10+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/New-Project-143.webp https://www.worldpharmaceuticals.net/news/bms-2seventy-to-halt-phase-3-study-of-abecma/ 2024-09-26T13:26:21+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/New-Project-146.webp https://www.worldpharmaceuticals.net/news/pfizer-initiates-global-withdrawal-of-scd-drug-oxbryta/ 2024-09-26T13:44:28+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/Logo_Outside.webp https://www.worldpharmaceuticals.net/news/keytruda-gets-mhlw-approval-for-lung-and-urothelial-cancers/ 2024-09-26T13:55:20+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/KEYTRUDA1-1.webp https://www.worldpharmaceuticals.net/news/bristol-myers-squibb-gets-fda-nod-for-cobenfy-to-treat-schizophrenia-in-adults/ 2024-09-27T07:11:17+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/New-Project-155.webp https://www.worldpharmaceuticals.net/news/evotec-partners-with-novo-nordisk-to-develop-stem-cell-based-therapies/ 2024-09-27T09:58:02+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/New-Project-157.webp https://www.worldpharmaceuticals.net/news/tagrisso-gets-fda-approval-for-stage-3-egfr-mutated-lung-cancer/ 2024-09-27T13:45:12+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/original.webp https://www.worldpharmaceuticals.net/news/abbvies-tavapadon-meets-primary-endpoint-in-phase-3-trial/ 2024-09-27T14:02:26+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/AbbVie-US-Headquarters-1.webp https://www.worldpharmaceuticals.net/news/regeneron-sanofis-dupixent-approved-to-treat-copd-in-us-china/ 2024-09-30T07:46:24+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/New-Project-167.webp https://www.worldpharmaceuticals.net/news/bluerocks-bemdaneprocel-shows-positive-results/ 2024-09-30T13:04:22+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/New-Project-169-1.webp https://www.worldpharmaceuticals.net/news/dr-reddys-swiss-subsidiary-acquires-haleons-nicotinell-portfolio-for-620m/ 2024-09-30T14:19:05+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/business-7533126_1920.webp https://www.worldpharmaceuticals.net/news/jjs-carvykti-extends-overall-survival-in-phase-3-multiple-myeloma-trial/ 2024-09-30T14:42:30+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/doctor-8733826_1920-1.webp https://www.worldpharmaceuticals.net/news/fresenius-kabi-formycon-fda-approval-for-otulfi/ 2024-10-01T08:13:20+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-179.webp https://www.worldpharmaceuticals.net/news/cenra-to-promote-modernas-mrna-vaccine-portfolio-in-taiwan/ 2024-10-01T13:37:55+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/mufid-majnun-6nnU2Da14b8-unsplash.webp https://www.worldpharmaceuticals.net/news/piramal-to-invest-80m-in-sterile-injectables-site-in-kentucky/ 2024-10-01T13:55:14+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/Piramal_Pharma_Solutions.webp https://www.worldpharmaceuticals.net/news/enhertu-gets-fda-priority-review-for-enhertu/ 2024-10-02T07:50:30+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-184.webp https://www.worldpharmaceuticals.net/news/gilead-to-boost-access-to-lenacapavir/ 2024-10-03T10:47:33+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-192.webp https://www.worldpharmaceuticals.net/news/lilly-to-invest-4-5bn-in-new-manufacturing-facility-in-indiana/ 2024-10-03T13:55:23+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-196.webp https://www.worldpharmaceuticals.net/news/jjs-erleada-shows-survival-benefits-at-24-months-trial-for-mcspc/ 2024-10-03T14:05:21+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/download-1-1.webp https://www.worldpharmaceuticals.net/news/novaliq-and-laboratoires-thea-get-ec-nod-for-vevizye/ 2024-10-03T14:12:12+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/towfiqu-barbhuiya-6F2mPewg2RA-unsplash.webp https://www.worldpharmaceuticals.net/news/astrazenecas-gets-fda-priority-review-for-calquence/ 2024-10-04T07:54:01+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-200.webp https://www.worldpharmaceuticals.net/news/ginkgo-virica-partner-to-advance-aav-gene-therapies/ 2024-10-04T11:07:19+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-203.webp https://www.worldpharmaceuticals.net/news/opdivo-gets-fda-approval-for-resectable-non-small-cell-lung-cancer/ 2024-10-04T12:52:40+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/upper-body-944557_1920.webp https://www.worldpharmaceuticals.net/news/teva-and-mabxience-expand-partnership-with-second-oncology-biosimilar/ 2024-10-04T13:03:31+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/Teva_Image_Mfg11.webp https://www.worldpharmaceuticals.net/news/nuhs-car-t-cell-therapy-shows-promise-in-leukaemia/ 2024-10-07T09:35:35+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-3.webp https://www.worldpharmaceuticals.net/news/recordati-to-acquire-sanofis-rare-disease-drug-enjaymo/ 2024-10-07T12:38:59+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-7.webp https://www.worldpharmaceuticals.net/news/telix-gets-health-canada-approval-for-label-expansion-of-illuccix/ 2024-10-07T14:10:19+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/laboratory-5721287_1280.webp https://www.worldpharmaceuticals.net/news/abl-bio-partners-with-msd-for-abl103-keytruda-trial-in-solid-tumour/ 2024-10-07T14:22:07+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/KEYTRUDA2-1.webp https://www.worldpharmaceuticals.net/news/astrazeneca-licenses-cspcs-pre-clinical-lipoprotein-disruptor/ 2024-10-08T07:53:13+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-19.webp https://www.worldpharmaceuticals.net/news/innovent-ask-pharm-partner-for-limertinib/ 2024-10-08T12:49:50+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-22.webp https://www.worldpharmaceuticals.net/news/johnson-johnson-halts-phase-3-sunrise-2-trial-of-tar-200-in-mibc/ 2024-10-08T13:17:56+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/download-1-2.webp https://www.worldpharmaceuticals.net/news/novo-nordisk-and-mylan-settle-us-patent-battles-for-ozempic-and-wegovy/ 2024-10-08T13:56:50+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/original.webp